Challenges of treating melanoma in situ , lentigo maligna type: is pathological clearance the gold standard?-Reference-Cited by-同舟云学术

Challenges of treating melanoma in situ , lentigo maligna type: is pathological clearance the gold standard?

Published:2017-05 Issue:5 Volume:176 Page:1115-1116
ISSN:0007-0963
Container-title:British Journal of Dermatology
language:en
Short-container-title:Br J Dermatol

Author:

Swetter S.M.¹

Affiliation:

1. Department of Dermatology; Pigmented Lesion and Melanoma Program; Stanford University Medical Center and Cancer Institute; 900 Blake Wilbur Drive, W3045 Stanford CA 94028 U.S.A

Publisher

Wiley

Subject

Dermatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bjd.15512/fullpdf

Reference5 articles.

1. Diagnostic utility and comparative immunohistochemical analysis of MITF-1 and SOX10 to distinguish melanoma in situ and actinic keratosis: a clinicopathological and immunohistochemical study of 70 cases;Buonaccorsi;Am J Dermatopathol,2014

2. Effect of topical imiquimod as primary treatment for lentigo maligna: the LIMIT-1 study;Marsden;Br J Dermatol,2017

3. Imiquimod and lentigo maligna: a search for prognostic features in a clinicopathological study with long-term follow-up;Powell;Br J Dermatol,2009

4. Imiquimod 5% cream as primary or adjuvant therapy for melanoma in situ, lentigo maligna type;Swetter;J Am Acad Dermatol,2015

5. A quantative systematic review of the efficacy of imiquimod monotherapy for lentigo maligna and an analysis of factors that affect tumor clearance;Mora;J Am Acad Dermatol,2015

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. RECURRENT LENTIGO MALIGNA: CONSERVATIVE CONTINUOUS TREATMENT WITH IMIQUIMOD OR REPEATED SURGERY? A LONG-TERM FOLLOW-UP DERMOSCOPIC CASE STUDY;Experimental Oncology;2023-06-26

2. Clinical features associated with the invasive component in lentigo maligna of the head and neck: A retrospective study of 175 cases;Annales de Dermatologie et de Vénéréologie;2022-12

3. Topical Imiquimod for Lentigo Maligna: Survival Analysis of 103 Cases With 17 Years Follow-up;J DRUGS DERMATOL;2021

4. Effectiveness of 5% Topical Imiquimod for Lentigo Maligna Treatment;Acta Dermato Venereologica;2019

5. Variation in the diagnosis and clinical management of lentigo maligna across Europe: a survey study among European Association of Dermatologists and Venereologists members;Journal of the European Academy of Dermatology and Venereology;2018-03-30